Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0003873 (
rheumatoid arthritis
)
53,068
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Serum amyloid A-activating factor-1 (SAF-1), a Cys(2)His(2)-type zinc finger transcription factor, regulates inflammation-induced expression of serum amyloid A protein that is linked to the pathogenesis of reactive amyloidosis,
rheumatoid arthritis
, and atherosclerosis. Here we report the identification of a novel splice variant,
SAF-2
, of the SAF family bearing strong sequence similarity to SAF-1. The N-terminal 426 amino acids of both SAF-1 and
SAF-2
are identical containing two polyalanine tracts, one proline-rich domain, and six zinc fingers. However, the C terminus of
SAF-2
containing two additional zinc fingers is different from SAF-1, which indicates the capability of different biochemical function. We show that
SAF-2
interacts more avidly with the SAF-binding element, but its transactivation potential is much lower than SAF-1. Furthermore, co-expression of
SAF-2
markedly suppresses SAF-1-regulated promoter function. Finally, we show that the level of
SAF-2
protein is reduced during many inflammatory conditions, whereas the SAF-1 protein level remains unchanged. Together, these data suggest that the relative abundance of
SAF-2
plays a critical role in the fine tuned regulation of inflammation-responsive genes that are controlled by SAF-1.
...
PMID:SAF-2, a splice variant of SAF-1, acts as a negative regulator of transcription. 1227 Sep 22